Yvonne Decory, MD
Psychiatry · Saco, MENPI 1548318546
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Corium, LLC accounts for 61.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $544 and has fallen 95.4% since, to $25 in 2025. Among psychiatry clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $23.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$580
- Ironshore Pharmaceuticals Inc.$196
- Johnson & Johnson$82
- Neurocrine Biosciences, Inc.$43
- Collegium Pharmaceutical, Inc.$25
- Supernus Pharmaceuticals, Inc.$12
What the payments were for
- Food & beverage$938100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 27 | $580 |
| Ironshore Pharmaceuticals Inc. | 8 | $196 |
| Johnson & Johnson | 1 | $82 |
| Neurocrine Biosciences, Inc. | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$938 in reported general payments places this provider in the 90th percentile of 167 psychiatry providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 36 | $18,712 |
| Clomipramine Hcl | 22 | $3,024 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 35 | $1,257 |
| Fluvoxamine Maleate | 25 | $1,050 |
| Propranolol Hcl ErPropranolol Hcl | 16 | $952 |
| Quetiapine Fumarate | 27 | $816 |
| Sertraline Hcl | 37 | $561 |
| Lorazepam | 63 | $373 |
| Risperidone | 27 | $364 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 16 | $354 |
| Olanzapine | 21 | $338 |
| Escitalopram Oxalate | 12 | $196 |
| Mirtazapine | 21 | $154 |
| Lithium Carbonate | 16 | $149 |
| Trazodone Hcl | 15 | $135 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Saco
- Ryan SmithEastport$92K
- Edward BilottiSouth Portland$88K
- Ira ScottBangor$27K
- Charmaine PatelBangor$17K
- Glenn CurrierPortland$8K
- Elliot GruenLewiston$7K
- David JonesArundel$5K
- Christine WhitePrinceton$2K
- Sally WeissBangor$2K
- Kenneth WhiteVinalhaven$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.